Implementation of the JACIE standards for a haematopoietic progenitor cell transplantation programme: A cost analysis

Bone Marrow Transplantation

Volumn 34, Issue 10, 2004, Pages 847-853

  Zahnd, D ^a   Leibundgut, K ^a   Zenhausern R ^a   Pabst, T ^a   Fontana, S ^a   Schneider, R ^a   Tobler, A ^a   Zwicky, Caroline ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cost analysis; JACIE; Prognitor cells; QMS; Stem cells

Indexed keywords

ARTICLE; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NURSE; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY CONTROL; SALARY; STANDARDIZATION; WORKING TIME;

ACADEMIC MEDICAL CENTERS; COSTS AND COST ANALYSIS; HEALTH PLAN IMPLEMENTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 7244222287     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704649     Document Type: Article

References (10)

1. Kvalheim G. EBMT and ISHAGE-Europe create a foundation for inspection and accreditation in Europe. Editorial. Cytotherapy 1999; 1: 363-364.
2. Warkentin PI, Nick L, Shpall EJ. FAHCT accreditation: common deficiencies during on-site inspections. Cytotherapy 2000; 2: 213-220.
3. Kvalheim G, Urbano-Ispizua A, Gratwohl A. FAHCT-JACIE workshop on accreditation for blood and marrow progenitor cell processing, collection and transplantation, Barcelona, Spain. Cytotherapy 2000; 2: 223-224.
4. Jarlier A, Charvet-Protat S. Can improving quality decrease hospital costs? Int J Qual Health Care 2000; 12: 125-131.
5. Cornish J, Peters C. Standards of stem cell transplantation: Part I: the accreditation of paediatric stem cell transplantation centres within the EBMT; Part II: intensive care units in paediatric stem cell transplantation; Part III: informed consent and sibling donor issues. Bone Marrow Transplant 2001; 28 (Suppl. 1): S4-S5.
6. JACIE. Accreditation manual for blood and marrow progenitor cell processing, collection and transplantation. From the Joint Accreditation Committee of ISHAGE-Europe and EBMT. May 1999.
7. Arpagaus M, Oppliger Leibundgut E, Zbären K et al. Validation of haematopoietic progenitor cell processing. Schweiz Med Forum 2003: (Suppl. 12): 67S (abstr. P423).
8. Klazinga N. Re-engineering trust: the adoption and adaptation of four models for external quality assurance of health care services in western European health care systems. Int J Qual Health Care 2000; 12: 183-189.
9. Wasserfallen JB. Cost benefit aspects of quality: is there a return on the investment? Rev Med Suisse Romande 2001; 121: 827-830.
10. Coffey RJ, Gaucher EM, Lyons P. TQM brings financial benefit to the University of Michigan Medical Centre. In: Neuhauser D (ed.). Clinical CQI: A Book of Readings 1995; pp 237-242.